Harnessing Cellular Immunity for Vaccination against Respiratory Viruses
Review
[키워드] activate
acute respiratory disease
acute respiratory syndrome
approach
Aside
B cell response
candidate
CD4+
CD8+ T cell
Cellular immune response
cellular immunity
Clinical sign
Coronavirus-2
Coronaviruses
Critical
detrimental
Efficacy and safety
examined
group
Health
humoral immune response
illness
immunocompromised individuals
immunopathology
Infants
Infection
Influenza
long-lasting
métapneumovirus
Mild
morbidity
Mortality
Nanoparticles
neutralizing antibody
Patient
Pneumonia
Protein
Research
respiratory
Respiratory illness
respiratory syncytial virus
respiratory viral
respiratory viral infections
respiratory viruses
response
rhinovirus
RNA
RNA vaccines
robust
RSV
SARS-CoV-2
severe disease
subunits
tested
These viruses
upper respiratory
vaccination
Vaccine
vaccine candidate
vaccine candidates
viral infection
virus
Virus-like particle
virus-like particles
viruses
VLPs
[DOI] 10.3390/vaccines8040783 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/vaccines8040783 PMC 바로가기 [Article Type] Review